Get started
Author

Julien Dugal‐Tessier

Observed names: Dugal-Tessier Julien, Dugal-Tessier, J., Dugal-Tessier, Julien, J. Dugal-Tessier, Julien Dugai‐Tessier, Julien Dugal-Tessier
ORCID: 0000-0002-5909-7308
Observed ORCID: 0000-0002-5909-7308
OpenAlex ID: A5071753638
An N‐Heterocyclic Carbene/Lewis Acid Strategy for the Stereoselective Synthesis of Spirooxindole Lactones
2012 · Julien Dugal‐Tessier, Elizabeth A. O'Bryan, et al. · Angewandte Chemie International Edition · 282
Antibody-Oligonucleotide Conjugates: A Twist to Antibody-Drug Conjugates
2021 · Julien Dugal-Tessier, Srinath Thirumalairajan, et al. · Journal of Clinical Medicine · 132
PDF
Phospha-organic chemistry: from molecules to polymers
2009 · Joshua I. Bates, Julien Dugal-Tessier, et al. · Dalton Transactions · 125
An N‐Heterocyclic Carbene/Lewis Acid Strategy for the Stereoselective Synthesis of Spirooxindole Lactones
2012 · Julien Dugal‐Tessier, Elizabeth A. O'Bryan, et al. · Angewandte Chemie · 100
Antibody–Drug Conjugate Payloads; Study of Auristatin Derivatives
2020 · Michinori Akaiwa, Julien Dugal-Tessier, et al. · Chemical and Pharmaceutical Bulletin · 76
PDF
Chiral Phosphaalkene−Oxazoline Ligands for the Palladium-Catalyzed Asymmetric Allylic Alkylation
2010 · Julien Dugal-Tessier, Gregory R. Dake, et al. · Organic Letters · 54
P,N-Chelate Complexes of Pd(II) and Pt(II) Based on a Phosphaalkene Motif: A Catalyst for the Overman−Claisen Rearrangement
2007 · Julien Dugal-Tessier, Gregory R. Dake, et al. · Organometallics · 45
Investigation of Hydrophilic Auristatin Derivatives for Use in Antibody Drug Conjugates
2017 · Brian A. Mendelsohn, Stuart D. Barnscher, et al. · Bioconjugate Chemistry · 43
Chiral Ligand Design: A Bidentate Ligand Incorporating an Acyclic Phosphaalkene
2008 · Julien Dugal‐Tessier, Gregory R. Dake, et al. · Angewandte Chemie International Edition · 37
Metabolism of an Oxime-Linked Antibody Drug Conjugate, AGS62P1, and Characterization of Its Identified Metabolite
2018 · Josh T. Snyder, Maria-Christina Malinao, et al. · Molecular Pharmaceutics · 34
Enantiomerically Pure Phosphaalkene–Oxazolines (PhAk‐Ox): Synthesis, Scope and Copolymerization with Styrene
2012 · Julien Dugal‐Tessier, Spencer C. Serin, et al. · Chemistry - A European Journal · 24
Synthesis and Evaluation of Dolastatin 10 Analogues Containing Heteroatoms on the Amino Acid Side Chains
2017 · Julien Dugal-Tessier, Stuart D. Barnscher, et al. · Journal of Natural Products · 18
Synthesis of functional phosphines with ortho‐substituted aryl groups: 2‐RC6H4PH2 and 2‐RC6H4P(SiMe3)2 (R = 2‐i‐Pr‐ or 2‐t‐Bu‐)
2010 · Julien Dugal‐Tessier, Paul‐Steffan Kuhn, et al. · Heteroatom Chemistry · 13
Phosphaalkenes
2012 · Julien Dugal‐Tessier, Eamonn D. Conrad, et al. · 11
Erratum: Synthesis of functional phosphines with ortho‐substituted aryl groups: 2‐RC6H4PH2 and 2‐RC6H4P(SiMe3)2 (R = i‐Pr‐ or t‐Bu)
2010 · Julien Dugal‐Tessier, Paul‐Steffan Kuhn, et al. · Heteroatom Chemistry · 4
PDF
Development of a translational murine model for antibody-drug conjugate-induced interstitial lung disease
2026 · Suresh Anaganti, Arti Bhujade, et al. · npj Precision Oncology · 2
Non-cleavable Linkers: Permanently Linked, for Better or for Worse
2021 · Julien Dugal-Tessier, Nareshkumar Jain · Royal Society of Chemistry eBooks · 2
Chiral Ligand Design: A Bidentate Ligand Incorporating an Acyclic Phosphaalkene
2008 · Julien Dugal‐Tessier, Gregory R. Dake, et al. · Angewandte Chemie · 2
Asymmetric Allylic Alkylation with Phosphaalkene-Oxazoline Ligands
2010 · D. Gates, J. Dugal-Tessier, et al. · Synfacts · 1
Abstract A001: A Murine Translational Platform for ADC-Associated ILD Supports Rational Linker Optimization and Development of ARK-101, a Low-Toxicity HER2 ADC
2026 · Suresh Anaganti, Arti Bhujade, et al. · Clinical Cancer Research
A first-in-class precision antibody conjugate targeting EGFR, mTOR, and PI3K to treat head and neck cancers
2026 · Martin Schnermann, Xiaoyi Li, et al. · Research Square
Abstract 2398: Dissecting ADC pulmonary toxicity: A murine ADC-associated ILD model to guide and inform ADC discovery.
2026 · Suresh Anaganti, Arti Bhujade, et al. · Cancer Research
Abstract 1679: Plate-based conjugation for antibody and payload optimization in ADC development
2026 · Zeinab Fereshteh, Madhavi Latha S. Chalasani, et al. · Cancer Research
Abstract 5741: siteDAR, complete antibody drug conjugate, ADC characterization
2024 · Warham L. Martin, Michael Senseney, et al. · Cancer Research
抗体-薬物複合体ペイロード:アウリスタチン誘導体の研究
2020 · Akaiwa Michinori, Dugal-Tessier Julien, et al.
Works count: 44
Citation count: 1,002
H-index: 13
I10-index: 14
Year
Topic
Type